Mutant prevention concentration as a measure of fluoroquinolone potency against mycobacteria

G. Sindelar, X. Zhao, A. Liew, Y. Dong, T. Lu, J. Zhou, J. Domagala, K. Drlica

Research output: Contribution to journalArticle

80 Citations (Scopus)

Abstract

Mutant prevention concentration (MPC) has been proposed as a new measure of antibiotic potency by which the ability to restrict selection of resistant mutants is evaluated. To determine whether MPC provides potency information unavailable from the more customary measurement of the MIC, 18 fluoroquinolones were examined for their ability to block the growth of Mycobacterium smegmatis and to select resistant mutants from wild-type populations. Both MPC and MIC were affected by changes in the moiety at the fluoroquinolone C-8 position and in alkyl groups attached to the C-7 piperazinyl ring. When eight resistant mutants, altered in the gyrase A protein, were tested with fluoroquinolones having either a methoxy or a hydrogen at the C-8 position, the MIC for the most resistant mutant correlated better with the MPC than did the MIC for wild-type cells. For C-8 fluorine derivatives, which were generally less active than the C-8-methoxy compounds but which were more active than C-8-hydrogen derivatives, the MICs for both the mutant and the wild type correlated well with the MPCs. Thus, measurement of the MICs for wild-type cells can reflect the ability of a quinolone to restrict the selection of resistance, but often it does not. With the present series of compounds, the most potent contained a C-8-methoxy and a small group attached to the C-7 ring.

Original languageEnglish (US)
Pages (from-to)3337-3343
Number of pages7
JournalAntimicrobial agents and chemotherapy
Volume44
Issue number12
DOIs
StatePublished - Dec 1 2000
Externally publishedYes

Fingerprint

Fluoroquinolones
Mycobacterium
Hydrogen
Mycobacterium smegmatis
Fluorine
Quinolones
Anti-Bacterial Agents
Growth
Population
Proteins

All Science Journal Classification (ASJC) codes

  • Pharmacology
  • Pharmacology (medical)
  • Infectious Diseases

Cite this

Sindelar, G. ; Zhao, X. ; Liew, A. ; Dong, Y. ; Lu, T. ; Zhou, J. ; Domagala, J. ; Drlica, K. / Mutant prevention concentration as a measure of fluoroquinolone potency against mycobacteria. In: Antimicrobial agents and chemotherapy. 2000 ; Vol. 44, No. 12. pp. 3337-3343.
@article{fdfb11d0ca3c48baaa06891d8f680687,
title = "Mutant prevention concentration as a measure of fluoroquinolone potency against mycobacteria",
abstract = "Mutant prevention concentration (MPC) has been proposed as a new measure of antibiotic potency by which the ability to restrict selection of resistant mutants is evaluated. To determine whether MPC provides potency information unavailable from the more customary measurement of the MIC, 18 fluoroquinolones were examined for their ability to block the growth of Mycobacterium smegmatis and to select resistant mutants from wild-type populations. Both MPC and MIC were affected by changes in the moiety at the fluoroquinolone C-8 position and in alkyl groups attached to the C-7 piperazinyl ring. When eight resistant mutants, altered in the gyrase A protein, were tested with fluoroquinolones having either a methoxy or a hydrogen at the C-8 position, the MIC for the most resistant mutant correlated better with the MPC than did the MIC for wild-type cells. For C-8 fluorine derivatives, which were generally less active than the C-8-methoxy compounds but which were more active than C-8-hydrogen derivatives, the MICs for both the mutant and the wild type correlated well with the MPCs. Thus, measurement of the MICs for wild-type cells can reflect the ability of a quinolone to restrict the selection of resistance, but often it does not. With the present series of compounds, the most potent contained a C-8-methoxy and a small group attached to the C-7 ring.",
author = "G. Sindelar and X. Zhao and A. Liew and Y. Dong and T. Lu and J. Zhou and J. Domagala and K. Drlica",
year = "2000",
month = "12",
day = "1",
doi = "10.1128/AAC.44.12.3337-3343.2000",
language = "English (US)",
volume = "44",
pages = "3337--3343",
journal = "Antimicrobial Agents and Chemotherapy",
issn = "0066-4804",
publisher = "American Society for Microbiology",
number = "12",

}

Mutant prevention concentration as a measure of fluoroquinolone potency against mycobacteria. / Sindelar, G.; Zhao, X.; Liew, A.; Dong, Y.; Lu, T.; Zhou, J.; Domagala, J.; Drlica, K.

In: Antimicrobial agents and chemotherapy, Vol. 44, No. 12, 01.12.2000, p. 3337-3343.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Mutant prevention concentration as a measure of fluoroquinolone potency against mycobacteria

AU - Sindelar, G.

AU - Zhao, X.

AU - Liew, A.

AU - Dong, Y.

AU - Lu, T.

AU - Zhou, J.

AU - Domagala, J.

AU - Drlica, K.

PY - 2000/12/1

Y1 - 2000/12/1

N2 - Mutant prevention concentration (MPC) has been proposed as a new measure of antibiotic potency by which the ability to restrict selection of resistant mutants is evaluated. To determine whether MPC provides potency information unavailable from the more customary measurement of the MIC, 18 fluoroquinolones were examined for their ability to block the growth of Mycobacterium smegmatis and to select resistant mutants from wild-type populations. Both MPC and MIC were affected by changes in the moiety at the fluoroquinolone C-8 position and in alkyl groups attached to the C-7 piperazinyl ring. When eight resistant mutants, altered in the gyrase A protein, were tested with fluoroquinolones having either a methoxy or a hydrogen at the C-8 position, the MIC for the most resistant mutant correlated better with the MPC than did the MIC for wild-type cells. For C-8 fluorine derivatives, which were generally less active than the C-8-methoxy compounds but which were more active than C-8-hydrogen derivatives, the MICs for both the mutant and the wild type correlated well with the MPCs. Thus, measurement of the MICs for wild-type cells can reflect the ability of a quinolone to restrict the selection of resistance, but often it does not. With the present series of compounds, the most potent contained a C-8-methoxy and a small group attached to the C-7 ring.

AB - Mutant prevention concentration (MPC) has been proposed as a new measure of antibiotic potency by which the ability to restrict selection of resistant mutants is evaluated. To determine whether MPC provides potency information unavailable from the more customary measurement of the MIC, 18 fluoroquinolones were examined for their ability to block the growth of Mycobacterium smegmatis and to select resistant mutants from wild-type populations. Both MPC and MIC were affected by changes in the moiety at the fluoroquinolone C-8 position and in alkyl groups attached to the C-7 piperazinyl ring. When eight resistant mutants, altered in the gyrase A protein, were tested with fluoroquinolones having either a methoxy or a hydrogen at the C-8 position, the MIC for the most resistant mutant correlated better with the MPC than did the MIC for wild-type cells. For C-8 fluorine derivatives, which were generally less active than the C-8-methoxy compounds but which were more active than C-8-hydrogen derivatives, the MICs for both the mutant and the wild type correlated well with the MPCs. Thus, measurement of the MICs for wild-type cells can reflect the ability of a quinolone to restrict the selection of resistance, but often it does not. With the present series of compounds, the most potent contained a C-8-methoxy and a small group attached to the C-7 ring.

UR - http://www.scopus.com/inward/record.url?scp=0034425797&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034425797&partnerID=8YFLogxK

U2 - 10.1128/AAC.44.12.3337-3343.2000

DO - 10.1128/AAC.44.12.3337-3343.2000

M3 - Article

VL - 44

SP - 3337

EP - 3343

JO - Antimicrobial Agents and Chemotherapy

JF - Antimicrobial Agents and Chemotherapy

SN - 0066-4804

IS - 12

ER -